These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22447251)

  • 1. The heat shock protein 90 inhibitor SNX-2112 inhibits B16 melanoma cell growth in vitro and in vivo.
    Liu KS; Ding WC; Wang SX; Liu Z; Xing GW; Wang Y; Wang YF
    Oncol Rep; 2012 Jun; 27(6):1904-10. PubMed ID: 22447251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SNX-2112, a novel Hsp90 inhibitor, induces G2/M cell cycle arrest and apoptosis in MCF-7 cells.
    Wang SX; Ju HQ; Liu KS; Zhang JX; Wang X; Xiang YF; Wang R; Liu JY; Liu QY; Xia M; Xing GW; Liu Z; Wang YF
    Biosci Biotechnol Biochem; 2011; 75(8):1540-5. PubMed ID: 21821931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hsp90 inhibitor SNX-2112, induces apoptosis in multidrug resistant K562/ADR cells through suppression of Akt/NF-κB and disruption of mitochondria-dependent pathways.
    Wang R; Shao F; Liu Z; Zhang J; Wang S; Liu J; Liu H; Chen H; Liu K; Xia M; Wang Y
    Chem Biol Interact; 2013 Sep; 205(1):1-10. PubMed ID: 23777986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers.
    Chandarlapaty S; Sawai A; Ye Q; Scott A; Silinski M; Huang K; Fadden P; Partdrige J; Hall S; Steed P; Norton L; Rosen N; Solit DB
    Clin Cancer Res; 2008 Jan; 14(1):240-8. PubMed ID: 18172276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK.
    Okawa Y; Hideshima T; Steed P; Vallet S; Hall S; Huang K; Rice J; Barabasz A; Foley B; Ikeda H; Raje N; Kiziltepe T; Yasui H; Enatsu S; Anderson KC
    Blood; 2009 Jan; 113(4):846-55. PubMed ID: 18948577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of SNX-2112, a synthetic heat shock protein-90 inhibitor, in MET-amplified tumor cells with or without resistance to selective MET Inhibition.
    Bachleitner-Hofmann T; Sun MY; Chen CT; Liska D; Zeng Z; Viale A; Olshen AB; Mittlboeck M; Christensen JG; Rosen N; Solit DB; Weiser MR
    Clin Cancer Res; 2011 Jan; 17(1):122-33. PubMed ID: 21208906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor activity of the HSP90 inhibitor SNX-2112 in pediatric cancer cell lines.
    Chinn DC; Holland WS; Yoon JM; Zwerdling T; Mack PC
    Pediatr Blood Cancer; 2012 Jun; 58(6):885-90. PubMed ID: 21796766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of SNX-7081 and SNX-2112 on cell cycle, apoptosis and Hsp90 client proteins in human cancer cells.
    Wang X; Wang S; Liu Y; Huang D; Zheng K; Zhang Y; Wang X; Liu Q; Yang D; Wang Y
    Oncol Rep; 2015 Jan; 33(1):230-8. PubMed ID: 25334086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective targeting of triple-negative breast cancer cells by PF-4942847, a novel oral inhibitor of Hsp 90.
    Mehta PP; Whalen P; Baxi SM; Kung PP; Yamazaki S; Yin MJ
    Clin Cancer Res; 2011 Aug; 17(16):5432-42. PubMed ID: 21715568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNX-2112, an Hsp90 inhibitor, induces apoptosis and autophagy via degradation of Hsp90 client proteins in human melanoma A-375 cells.
    Liu KS; Liu H; Qi JH; Liu QY; Liu Z; Xia M; Xing GW; Wang SX; Wang YF
    Cancer Lett; 2012 May; 318(2):180-8. PubMed ID: 22182451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsp90 inhibitor induces KG-1a cell differentiation and apoptosis via Akt/NF-κB signaling.
    Qin JH; Wang K; Fu XL; Zhou PJ; Liu Z; Xu DD; Wang YF; Yang DP; Xie QL; Liu QY
    Oncol Rep; 2017 Sep; 38(3):1517-1524. PubMed ID: 28713903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hsp90 inhibitor SNX-2112 induces apoptosis of human hepatocellular carcinoma cells: the role of ER stress.
    Wang X; Wang S; Liu Y; Ding W; Zheng K; Xiang Y; Liu K; Wang D; Zeng Y; Xia M; Yang D; Wang Y
    Biochem Biophys Res Commun; 2014 Mar; 446(1):160-6. PubMed ID: 24582562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway.
    Siwak DR; Shishodia S; Aggarwal BB; Kurzrock R
    Cancer; 2005 Aug; 104(4):879-90. PubMed ID: 16007726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FM807, a curcumin analogue, shows potent antitumor effects in nasopharyngeal carcinoma cells by heat shock protein 90 inhibition.
    Ye M; Huang W; Wu WW; Liu Y; Ye SN; Xu JH
    Oncotarget; 2017 Feb; 8(9):15364-15376. PubMed ID: 28157708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of SNX-2112 with 5-FU exhibits antagonistic effect in esophageal cancer cells.
    Liu Y; Wang X; Wang Y; Zhang Y; Zheng K; Yan H; Zhang L; Chen W; Wang X; Liu Q; Wang S; Wang Y
    Int J Oncol; 2015 Jan; 46(1):299-307. PubMed ID: 25333998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein 90 inhibitor mycoepoxydiene modulates kinase signaling in cervical cancer cells and inhibits in-vivo tumor growth.
    Lin P; Yi Y; Lu M; Wang M; Yang Y; Lu Y; Song S; Zheng Z; Deng X; Zhang L
    Anticancer Drugs; 2015 Jan; 26(1):25-34. PubMed ID: 25014191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNX-2112 Induces Apoptosis and Autophagy of Nara-H Cells.
    Fukuoka N; Nakamura O; Yamagami Y; Nishimura H; Ishibashi Y; Yamamoto T
    Anticancer Res; 2018 Sep; 38(9):5177-5181. PubMed ID: 30194165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines.
    Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2348-56. PubMed ID: 18281615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
    Schwock J; Pham NA; Cao MP; Hedley DW
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis.
    Rice JW; Veal JM; Fadden RP; Barabasz AF; Partridge JM; Barta TE; Dubois LG; Huang KH; Mabbett SR; Silinski MA; Steed PM; Hall SE
    Arthritis Rheum; 2008 Dec; 58(12):3765-75. PubMed ID: 19035474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.